Publication:
Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?

Simple item page
dc.contributor.authorVEZİR, DUYGU
dc.contributor.authorKOCAKAYA, DERYA
dc.contributor.authorMERCANCI, ZEYNEP
dc.contributor.authorKARAKURT, SAİT
dc.contributor.authorsVezir D., Yildizeli S. O., KOCAKAYA D., Mercanci Z., Balcan B., Cinar C., Eryuksel E., KARAKURT S.
dc.date.accessioned2023-06-19T07:37:16Z
dc.date.accessioned2026-01-10T21:22:59Z
dc.date.available2023-06-19T07:37:16Z
dc.date.issued2022-09-01
dc.identifier.citationVezir D., Yildizeli S. O., KOCAKAYA D., Mercanci Z., Balcan B., Cinar C., Eryuksel E., KARAKURT S., "Does preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?", EUROPEAN RESPIRATORY JOURNAL, cilt.60, 2022
dc.identifier.doi10.1183/13993003.congress-2022.2597
dc.identifier.issn0903-1936
dc.identifier.urihttps://hdl.handle.net/11424/290365
dc.identifier.volume60
dc.language.isoeng
dc.relation.ispartofEUROPEAN RESPIRATORY JOURNAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectChest Diseases and Allergy
dc.subjectHealth Sciences
dc.subjectSOLUNUM SİSTEMİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectRESPIRATORY SYSTEM
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectSolunum Bakımı
dc.subjectAkciğer ve Solunum Tıbbı
dc.subjectRespiratory Care
dc.subjectPulmonary and Respiratory Medicine
dc.subjectCritically ill patients
dc.subjectHypoxia
dc.subjectComorbidities
dc.titleDoes preexisting immuncompromised status prevent mortality in COVID-19 patients: friend or foe?
dc.typearticle
dspace.entity.typePublication

Files

Collections

Araştırma Çıktıları